Teva Pharmaceutical Industries TEVA
NYSE TEVA
$37.29 -0.18 (-0.48%)
At close: Aug 20, 2026 · 10:54 AM UTC

Teva Pharmaceutical Industries (TEVA) Change in Accured Expenses (2025 - 2026)

Teva Pharmaceutical Industries' (TEVA) quarterly Change in Accured Expenses came in at $82.0 million in Q2 2026, down 2.38% YoY from $84.0 million in Q2 2025, and up 156.94% on a QoQ basis from -$144.0 million in Q1 2026.

Teva Pharmaceutical Industries (TEVA) Change in Accured Expenses (2025 - 2026) Analysis & Trends

Teva Pharmaceutical Industries (TEVA) has 2 years of Change in Accured Expenses data on file, last reported at $82.0 million in Q2 2026.

  • Quarterly Change in Accured Expenses fell 2.38% year-over-year to $82.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$19.0 million (changed N/A YoY) and the FY2025 annual result came in at -$15.0 million, down 105.81% from the prior year.
  • Change in Accured Expenses rose to $82.0 million in Q2 2026, from -$144.0 million in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $84.0 million in Q2 2025 to a low of -$144.0 million in Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Haleon 43.76 Bn 42.79 Bn - -
2 Teva Pharmaceutical Industries 43.38 Bn 39.73 Bn 2.15 Bn 82.00 Mn
3 Zoetis 31.61 Bn 29.93 Bn 1.05 Bn 142.00 Mn
4 Takeda Pharmaceutical 28.64 Bn 22.84 Bn 5.10 Bn -219.00 Mn
5 United Therapeutics 22.20 Bn 19.54 Bn 683.80 Mn -4.00 Mn
6 Viatris 18.82 Bn 17.93 Bn 1.46 Bn -
7 Neurocrine Biosciences 15.67 Bn 15.28 Bn 935.80 Mn -8.50 Mn
8 Elanco Animal Health 12.11 Bn 11.58 Bn 798.00 Mn -
9 Dr Reddys Laboratories 10.10 Bn 9.94 Bn - -
10 Alkermes 8.21 Bn 7.55 Bn 397.90 Mn 41.19 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 82.00 Mn
Jun 30, 2026 82.00 Mn
Mar 31, 2026 -144.00 Mn
Mar 31, 2026 -144.00 Mn
Jun 30, 2025 84.00 Mn
Jun 30, 2025 84.00 Mn
Mar 31, 2025 -41.00 Mn
Mar 31, 2025 -41.00 Mn